Eli Lilly and CompanyLLY

Healthcare
Bullish

ASignal's systematic analysis rates LLY as Bullish. Eli Lilly and Company has a market cap of $1.06T, a P/E of 43.28, a 35.0% net margin, and 55.5% year-over-year revenue growth.

Reflects the latest available analysis · analyzed Jul 11, 2026

The case on LLY

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong revenue growth (55.5% YoY)
  • Exceptional return on equity (107.46%)
  • High gross and operating margins (82.83%, 49.39%)
  • Positive free cash flow ($9.16B)
  • Analyst coverage from reputable sources including SeekingAlpha and Bloomberg-equivalent outlets
VS
Bear case
  • Overbought RSI at 65.5 (approaching 70 threshold)
  • MACD histogram negative and declining trend momentum
  • High valuation metrics (P/E 43.28x, P/B 34.04x)
  • Debt-to-equity ratio elevated at 1.39x
  • Low Reddit retail interest (only 1 mention)

Key facts

Sector
Healthcare
Market cap
$1.06T
P/E ratio
43.28
Gross margin
82.8%
Net margin
35.0%
Rev growth YoY
55.5%
Price (Jul 11, 2026)
$1,188.58

Peers

Clustered with LLY by analysis-profile similarity.

Subscriber-only

See the full verdict on LLY

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes LLY

Most investors never get a second opinion, let alone several. ASignal runs LLY past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

Eli Lilly and Company (LLY) Stock Analysis - ASignal rates it Bullish